BRONCHIOLITIS OBLITERANS SYNDROME
Clinical trials for BRONCHIOLITIS OBLITERANS SYNDROME explained in plain language.
Never miss a new study
Get alerted when new BRONCHIOLITIS OBLITERANS SYNDROME trials appear
Sign up with your email to follow new studies for BRONCHIOLITIS OBLITERANS SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for lung damage after transplant: experimental drug shows promise
Disease control Recruiting nowThis study tests a drug called belumosudil for people who develop a serious lung condition (bronchiolitis obliterans syndrome) after a stem cell transplant. The goal is to see if the drug can improve lung function or slow the disease. About 45 participants with new or early-stage…
Matched conditions: BRONCHIOLITIS OBLITERANS SYNDROME
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New inhaled drug aims to halt lung transplant rejection
Disease control Recruiting nowThis study tests an inhaled drug called LAM-001 in 30 lung transplant patients who have developed chronic rejection (BOS). Participants will inhale LAM-001 or a placebo daily for 48 weeks. Researchers will check if the drug is safe and can slow the decline in lung function.
Matched conditions: BRONCHIOLITIS OBLITERANS SYNDROME
Phase: PHASE2 • Sponsor: Steven Hays, MD • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New MRI breathing test could spot lung disease in kids faster
Diagnosis Recruiting nowThis study looks at whether special MRI scans and breathing tests can help doctors diagnose bronchiolitis obliterans syndrome (BOS) earlier in children who have had a stem cell transplant. About 15 children aged 6 to 17 will do breathing tests and an MRI while holding their breat…
Matched conditions: BRONCHIOLITIS OBLITERANS SYNDROME
Sponsor: The Hospital for Sick Children • Aim: Diagnosis
Last updated May 20, 2026 11:55 UTC
-
Lung disease after transplant: are viruses to blame?
Knowledge-focused Recruiting nowThis study watches 250 people who had a donor stem cell transplant to see if respiratory viruses lead to a lung condition called bronchiolitis obliterans syndrome (BOS). Participants use a simple home device to check their lung function regularly. The goal is to learn how viruses…
Matched conditions: BRONCHIOLITIS OBLITERANS SYNDROME
Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 04:37 UTC